Pharma & Biotech Intellectual Property Masterclass "Managing IP for greater portfolio value, timely product launches and R&D success" Successful Pharma & Biotech companies understand that IP and patenting practices are essential in facilitating enhanced market exclusivity and revenue returns. The legal environment, patent and regulatory uncertainty in particular, is becoming a big challenge for operating globally. With problems with drug registration in the new emerging markets and counterfeit drugs flooding the markets, the industry is taking all the legal steps possible to protect their profits and good name. This Masterclass will bring together the experts to benchmark the best practices in developing, implementing and improving IP, as well as patent & litigation strategies. Join us in Amsterdam and understand, how to grasp the opportunities that the new unitary patent offers and what is the reality of the Unified Patent Court. More at: http://pharma.flemingeurope.com/pharma-biotech-property-masterclass